At Relief Therapeutics, we are leveraging our strength and experience to identify monogenic disorders in therapeutic areas that align with our areas of focus, such as rare metabolic diseases. We are actively seeking strategic relationships and creative collaborations with biopharmaceutical partners that have rare disease assets as well as with leading academic institutions that are developing these emerging technologies. We want to work with innovators who share our commitment and focus to bring these pioneering medicines to patients.